DeutschNewstral
Article
bizjournals.com on 2020-05-22 14:00
Advanced gene therapies pose new questions
Related news
- How much should it cost to save a life? Gene and cell therapies raise new questions about price versus valuebizjournals.com
New treatment therapies available for advanced prostate cancerThe Wichita Eagle
FDA Announces New Policies to Advance Cell and Gene Therapiesjdsupra.com- Castle Creek to collaborate with Mayo Clinic on developing new gene therapies for rare diseasesbizjournals.com
- KExclusive Report: What’s New in Gene Therapies for Tumor Treatment Market for 2021. Find Out Here!ksusentinel.com
- SNew way for states to cover pricey gene therapies will start with sickle cell diseasestateline.org
New Gene Therapies Might Never Reach the Minority Communities That Need Themphillymag.com- The FDA Approves Two New Gene Therapies for the Treatment of Sickle Cell Diseasejdsupra.com
Missouri, give sickle cell disease patients a better chance with new gene therapies | Opinionkansascity.com- New IPO could value Taysha Gene Therapies at nearly $700 millionbizjournals.com
ICER’s Positive Cost-Effectiveness Assessment Lends Support For New Sickle Cell Disease Gene TherapiesForbes- Scout Bio licenses new Penn technology to help develop gene therapies for petsbizjournals.com
Breakthroughs bring gene editing therapies into viewThe Japan Times
Advanced therapies exist for older catsabqjournal.com
Gene therapies must become miracles of medicineThe Economist
Cancer Researchers Turn Focus to Gene TherapiesThe New York Times- Reform Payment Models to Encourage Gene TherapiesForbes
- FGene therapies test Europe’s willingness to payft.com
- Passage Bio co-founders launch new company with $200M to fund gene therapies coming out of Pennbizjournals.com
Promising new gene therapies for sickle cell are out of reach in countries where they're needed mostoanow.com